Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-018449
Filing Date
2022-05-06
Accepted
2022-05-06 07:11:01
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q srra-10q_20220331.htm   iXBRL 10-Q 2197522
2 EX-10.4 srra-ex104_33.htm EX-10.4 945401
3 EX-31.1 srra-ex311_10.htm EX-31.1 9802
4 EX-31.2 srra-ex312_6.htm EX-31.2 9803
5 EX-32.1 srra-ex321_7.htm EX-32.1 7245
6 EX-32.2 srra-ex322_9.htm EX-32.2 7307
7 GRAPHIC gysjg3hx0g22000001.jpg GRAPHIC 2339
  Complete submission text file 0001564590-22-018449.txt   8326868

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA srra-20220331.xsd EX-101.SCH 52994
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20220331_cal.xml EX-101.CAL 43257
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20220331_def.xml EX-101.DEF 192380
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20220331_lab.xml EX-101.LAB 407386
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20220331_pre.xml EX-101.PRE 299724
63 EXTRACTED XBRL INSTANCE DOCUMENT srra-10q_20220331_htm.xml XML 1137919
Mailing Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404
Business Address 1820 GATEWAY DRIVE SUITE 110 SAN MATEO CA 94404 (605) 376-8679
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 22898817
SIC: 2834 Pharmaceutical Preparations